Hims & Hers’ stock is up after ending its lawsuit with Novo Nordisk. The deal shows that industry power lies with the drugmakers.
Source: https://www.fool.com/investing/2026/03/17/top-sp-500-stocks-…
T-Mobile and Otis Worldwide are attractively valued companies with strong fundamentals and dividend growth potential. TMUS offers robust double-digit growth forecasts, a low payout ratio, and significant upside to a $393 price target by 2028. Otis faces near-term margin pressures due to China headwinds but still expects high single-digit earnings growth for 2025.
McKinsey estimates the market could be valued at $1 trillion or more in the next decade. IonQ is one of the leading pure plays on quantum computing, and it’s already experiencing significant revenue growth.
The U.S. cannabis industry continues to evolve as legalization momentum slowly expands. Sales have grown across both medical and adult-use markets.
